Implementation of a clinical research “One Signature Initiative” at a large academic medical center

A clinical research team’s goal is to support the implementation, conduct, and monitoring of research studies and corresponding protocols. There is a need to ensure that study teams have adequate resources and regulatory support to successfully adhere to regulations and good clinical research practi...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth Elin Robison, Trina Lynn Moy, Katelyn Leanna Trigg
Format: Article
Language:English
Published: Cambridge University Press 2024-01-01
Series:Journal of Clinical and Translational Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2059866124006678/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526386413535232
author Elizabeth Elin Robison
Trina Lynn Moy
Katelyn Leanna Trigg
author_facet Elizabeth Elin Robison
Trina Lynn Moy
Katelyn Leanna Trigg
author_sort Elizabeth Elin Robison
collection DOAJ
description A clinical research team’s goal is to support the implementation, conduct, and monitoring of research studies and corresponding protocols. There is a need to ensure that study teams have adequate resources and regulatory support to successfully adhere to regulations and good clinical research practices. Our team, the UC Davis Division of Infectious Diseases Research Unit (IDRU), sought to establish a One Signature Initiative program for all studies and protocols supported by the IDRU. The One Signature Initiative designates one point of contact from each ancillary team or department to sign delegation and training logs, who in turn is delegated to train their team. The goals of the One Signature Initiative were, and are still, to reduce task redundancy, lessen regulatory burden on research teams, and minimize audit findings. Since the implementation of the One Signature Initiative in 2023, acceptance has been favorable, and we have expanded its footprint by incorporating it into our standard operating procedures. This article discusses our experiences, and ancillary departments’ experiences, with the One Signature Initiative. Our experience is an example of how a One Signature Initiative can be developed that is efficient, effective, and well-accepted by clinical research stakeholders.
format Article
id doaj-art-e8b11ca94e9646ce832f2a41dfa79f1d
institution Kabale University
issn 2059-8661
language English
publishDate 2024-01-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj-art-e8b11ca94e9646ce832f2a41dfa79f1d2025-01-16T21:53:29ZengCambridge University PressJournal of Clinical and Translational Science2059-86612024-01-01810.1017/cts.2024.667Implementation of a clinical research “One Signature Initiative” at a large academic medical centerElizabeth Elin Robison0Trina Lynn Moy1Katelyn Leanna Trigg2https://orcid.org/0000-0002-2031-0810UC Davis Health, Sacramento, CA, USAUC Davis Health, Sacramento, CA, USAUC Davis Health, Sacramento, CA, USAA clinical research team’s goal is to support the implementation, conduct, and monitoring of research studies and corresponding protocols. There is a need to ensure that study teams have adequate resources and regulatory support to successfully adhere to regulations and good clinical research practices. Our team, the UC Davis Division of Infectious Diseases Research Unit (IDRU), sought to establish a One Signature Initiative program for all studies and protocols supported by the IDRU. The One Signature Initiative designates one point of contact from each ancillary team or department to sign delegation and training logs, who in turn is delegated to train their team. The goals of the One Signature Initiative were, and are still, to reduce task redundancy, lessen regulatory burden on research teams, and minimize audit findings. Since the implementation of the One Signature Initiative in 2023, acceptance has been favorable, and we have expanded its footprint by incorporating it into our standard operating procedures. This article discusses our experiences, and ancillary departments’ experiences, with the One Signature Initiative. Our experience is an example of how a One Signature Initiative can be developed that is efficient, effective, and well-accepted by clinical research stakeholders.https://www.cambridge.org/core/product/identifier/S2059866124006678/type/journal_articleTrainingregulatoryclinical trial managementdelegation of authorityquality assurance
spellingShingle Elizabeth Elin Robison
Trina Lynn Moy
Katelyn Leanna Trigg
Implementation of a clinical research “One Signature Initiative” at a large academic medical center
Journal of Clinical and Translational Science
Training
regulatory
clinical trial management
delegation of authority
quality assurance
title Implementation of a clinical research “One Signature Initiative” at a large academic medical center
title_full Implementation of a clinical research “One Signature Initiative” at a large academic medical center
title_fullStr Implementation of a clinical research “One Signature Initiative” at a large academic medical center
title_full_unstemmed Implementation of a clinical research “One Signature Initiative” at a large academic medical center
title_short Implementation of a clinical research “One Signature Initiative” at a large academic medical center
title_sort implementation of a clinical research one signature initiative at a large academic medical center
topic Training
regulatory
clinical trial management
delegation of authority
quality assurance
url https://www.cambridge.org/core/product/identifier/S2059866124006678/type/journal_article
work_keys_str_mv AT elizabethelinrobison implementationofaclinicalresearchonesignatureinitiativeatalargeacademicmedicalcenter
AT trinalynnmoy implementationofaclinicalresearchonesignatureinitiativeatalargeacademicmedicalcenter
AT katelynleannatrigg implementationofaclinicalresearchonesignatureinitiativeatalargeacademicmedicalcenter